Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Perseus Proteomics, Inc. ( (JP:4882) ) has shared an announcement.
Perseus Proteomics Inc. announced a strategic financial restructuring involving the reduction of capital stock and capital reserve to offset a significant deficit in retained earnings. This move is intended to strengthen the company’s financial base without affecting the total number of issued shares or the net assets per share, ensuring stability for shareholders and stakeholders.
More about Perseus Proteomics, Inc.
Perseus Proteomics Inc. operates in the biotechnology industry, focusing on the development and commercialization of therapeutic antibodies. The company is listed on the Tokyo Stock Exchange under the securities code 4882, and it aims to address various medical needs through its innovative products.
Average Trading Volume: 1,424,566
Technical Sentiment Signal: Sell
Current Market Cap: Yen6.48B
See more data about 4882 stock on TipRanks’ Stock Analysis page.